These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33524308)

  • 1. Black Women Are More Likely Than White Women to Schedule a Uterine-Sparing Treatment for Leiomyomas.
    Wegienka G; Stewart EA; Nicholson WK; Zhang S; Li F; Thomas L; Spies JB; Venable S; Laughlin-Tommaso S; Diamond MP; Anchan RM; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
    J Womens Health (Larchmt); 2021 Mar; 30(3):355-366. PubMed ID: 33524308
    [No Abstract]   [Full Text] [Related]  

  • 2. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
    Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
    Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry.
    Anchan RM; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL; Spies JB
    J Womens Health (Larchmt); 2023 Apr; 32(4):423-433. PubMed ID: 36637808
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
    Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
    Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
    Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
    Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Characteristics Associated With Embolization Versus Hysterectomy for Uterine Fibroids: A Systematic Review and Meta-Analysis.
    Srinivas T; Lulseged B; Mirza Aghazadeh Attari M; Borahay M; Weiss CR
    J Am Coll Radiol; 2024 May; 21(5):729-739. PubMed ID: 38191081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
    Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER
    Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomized controlled trial.
    Sirkeci F; Moss J; Belli AM; McPherson K; Daniels J; Manyonda I; Middleton L; Cheed V; Wu O; Lumsden MA;
    Int J Gynaecol Obstet; 2023 Feb; 160(2):492-501. PubMed ID: 36511801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Patient Characteristics and Treatment Procedure Among Patients With Uterine Leiomyomas.
    Borah BJ; Laughlin-Tommaso SK; Myers ER; Yao X; Stewart EA
    Obstet Gynecol; 2016 Jan; 127(1):67-77. PubMed ID: 26646122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive myomectomy: practice trends and differences between Black and non-Black women within a large integrated healthcare system.
    Zaritsky E; Le A; Tucker LY; Ojo A; Weintraub MR; Raine-Bennett T
    Am J Obstet Gynecol; 2022 Jun; 226(6):826.e1-826.e11. PubMed ID: 35101407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
    Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
    Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine Fibroids in Black Women: A Race-Stratified Subgroup Analysis of Treatment Outcomes After Laparoscopic Radiofrequency Ablation.
    Berman JM; Bradley L; Hawkins SM; Levy B
    J Womens Health (Larchmt); 2022 Apr; 31(4):593-599. PubMed ID: 34287028
    [No Abstract]   [Full Text] [Related]  

  • 13. Pre-operative uterine artery embolization before hysterectomy or myomectomy: a single-center review of 53 patients.
    Kinariwala DJ; Khaja MS; McCann S; Sheeran D; Park AW; Wilkins LR; Matsumoto AH; Redick DL
    Clin Imaging; 2023 Sep; 101():121-125. PubMed ID: 37329639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database.
    Borah BJ; Yao X; Laughlin-Tommaso SK; Heien HC; Stewart EA
    Obstet Gynecol; 2017 Nov; 130(5):1047-1056. PubMed ID: 29016510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids.
    Harrington A; Bonine NG; Banks E; Shih V; Stafkey-Mailey D; Fuldeore RM; Yue B; Ye JM; Ta JT; Gillard P
    J Manag Care Spec Pharm; 2020 Jan; 26(1-a Suppl):S2-S10. PubMed ID: 31958025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
    McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
    Trials; 2014 Nov; 15():468. PubMed ID: 25432688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
    Coyne KS; Margolis MK; Murphy J; Spies J
    Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids.
    Davis MR; Soliman AM; Castelli-Haley J; Snabes MC; Surrey ES
    J Womens Health (Larchmt); 2018 Oct; 27(10):1204-1214. PubMed ID: 30085898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical myomectomy followed by oral Myfembree vs standard of care (SOUL trial): Study protocol for a randomized control trial.
    Alkhrait S; Al-Hendy A; Alkelani H; Karrison T; Laveaux OSM
    PLoS One; 2024; 19(7):e0306053. PubMed ID: 38954680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.